Corcept Therapeutics | CORT - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Ardelyx USD -29.77M 35.79M 2026-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
J&J USD 8.27B 1.08B 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06